Ticker Details
Insulet Corporation Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
IPO Date:	May 15, 2007
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$13.81B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.78 | 1.88%
Avg Daily Range (30 D):	$2.61 | 1.17%
Avg Daily Range (90 D):	$3.47 | 1.32%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	.77M
Avg Daily Volume (90 D):	.75M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	29
Avg Trade Size (Sh.) (90 D):	28

Institutional Trades
Total Institutional Trades:	10,101
Avg Institutional Trade:	$6.21M
Avg Institutional Trade (30 D):	$19.85M
Avg Institutional Trade (90 D):	$17.04M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$11.25M
Avg Closing Trade (30 D):	$37.44M
Avg Closing Trade (90 D):	$34.47M
Avg Closing Volume:	59.07K

News

Mar 15, 2026 @ 11:05 PM This Biotech Stock Up Nearly 100% in a Year Has Dr... Source: Jonathan Ponciano

Mar 13, 2026 @ 1:45 PM Insulet Stock Hits 52-Week Low - Here's Why Source: Vandana Singh

Feb 13, 2026 @ 4:26 PM Accessible Health Platforms Gain Scale Across $6T ... Source: Prnewswire

Jan 19, 2026 @ 2:00 PM BVI Appoints Jim Hollingshead as President & Chief... Source: David Chavez

Aug 7, 2025 @ 5:50 PM Insulet Peer Tandem Diabetes Underwhelming Earning... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.51	$1.44	$3.51
Diluted EPS	$3.48	$1.43	$3.48
Revenue	$2.71B	$783.8M	$2.71B
Gross Profit	$1.94B	$568.6M	$1.94B
Net Income / Loss	$247.1M	$101.6M	$247.1M
Operating Income / Loss	$473.8M	$146.3M	$473.8M
Cost of Revenue	$768.2M	$215.2M	$768.2M
Net Cash Flow	$-237.2M	$-41.3M	$-237.2M
PE Ratio	56.32